Patrick R. Sosnay
Vertex Pharmaceuticals (United States)
ORCID: 0000-0002-4798-6394Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials”.
Lael M. Yonker, F. Vermeulen, Dario Prais, Rachel W. Linnemann, Aaron Trimble +92 more
Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more
Ajay S. Kasi, Jessica E. Pittman, Renée Jensen, L. Thia, Philip Robinson +44 more
Harriet Corvol, Patrick R. Sosnay, Rhonda G. Pace, Garry R. Cutting, John McGready +7 more